Total Payments
$368,990
2024 Payments
$30,717
Companies
33
Transactions
703
Medicare Patients
2,000
Medicare Billing
$302,295
Payment Breakdown by Category
Other$142,086 (38.5%)
Consulting$128,300 (34.8%)
Travel$46,333 (12.6%)
Food & Beverage$28,042 (7.6%)
Research$24,073 (6.5%)
Education$155.76 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $142,086 | 49 | 38.5% |
| Consulting Fee | $128,300 | 32 | 34.8% |
| Travel and Lodging | $46,333 | 122 | 12.6% |
| Food and Beverage | $28,042 | 483 | 7.6% |
| Unspecified | $24,073 | 12 | 6.5% |
| Education | $155.76 | 5 | 0.0% |
Payments by Type
General
$344,917
691 transactions
Research
$24,073
12 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Actelion Pharmaceuticals US, Inc. | $123,542 | 283 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $72,189 | 71 | $0 (2024) |
| United Therapeutics Corporation | $70,033 | 80 | $0 (2024) |
| Gilead Sciences, Inc. | $58,313 | 76 | $0 (2018) |
| Merck Sharp & Dohme LLC | $12,383 | 24 | $0 (2023) |
| Janssen Scientific Affairs, LLC | $8,775 | 1 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $5,120 | 20 | $0 (2023) |
| Acceleron Pharma, Inc. | $3,900 | 1 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $3,261 | 6 | $0 (2024) |
| Globus Medical, Inc. | $2,953 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $30,717 | 82 | United Therapeutics Corporation ($17,682) |
| 2023 | $52,345 | 90 | Bayer Healthcare Pharmaceuticals Inc. ($18,424) |
| 2022 | $9,231 | 91 | Actelion Pharmaceuticals US, Inc. ($3,610) |
| 2021 | $21,959 | 68 | Bayer HealthCare Pharmaceuticals Inc. ($8,578) |
| 2020 | $36,347 | 29 | United Therapeutics Corporation ($21,130) |
| 2019 | $44,225 | 92 | United Therapeutics Corporation ($15,658) |
| 2018 | $73,382 | 116 | Actelion Pharmaceuticals US, Inc. ($40,232) |
| 2017 | $100,783 | 135 | Actelion Pharmaceuticals US, Inc. ($41,506) |
All Payment Transactions
703 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $25.76 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/19/2024 | AngioDynamics, Inc. | ALPHAVAC (Device) | Food and Beverage | In-kind items and services | $52.06 | General |
| Category: VIT | ||||||
| 12/05/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $143.35 | General |
| Category: Cardiology | ||||||
| 12/04/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $29.76 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/20/2024 | Actelion Pharmaceuticals US, Inc. | — | Food and Beverage | In-kind items and services | $26.50 | General |
| 11/19/2024 | United Therapeutics Corporation | REMODULIN (Drug), TYVASO | Food and Beverage | In-kind items and services | $39.06 | General |
| Category: Pulmonary Arterial Hypertension | ||||||
| 11/13/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $53.01 | General |
| Category: VTE | ||||||
| 10/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: Cardio-renal | ||||||
| 10/21/2024 | United Therapeutics Corporation | ORENITRAM (Drug), REMODULIN, TYVASO | Consulting Fee | Cash or cash equivalent | $8,700.00 | General |
| Category: Pulmonary Arterial Hypertension | ||||||
| 10/08/2024 | United Therapeutics Corporation | ORENITRAM (Drug), REMODULIN, TYVASO | Food and Beverage | In-kind items and services | $144.00 | General |
| Category: Pulmonary Arterial Hypertension | ||||||
| 10/08/2024 | Globus Medical, Inc. | Excelsius3D Imaging System (Device) | Food and Beverage | In-kind items and services | $138.92 | General |
| Category: Spine/Spine Surgery | ||||||
| 10/03/2024 | Actelion Pharmaceuticals US, Inc. | — | Food and Beverage | In-kind items and services | $5.21 | General |
| 09/18/2024 | United Therapeutics Corporation | REMODULIN (Drug) | Food and Beverage | In-kind items and services | $103.71 | General |
| Category: Pulmonary Arterial Hypertension | ||||||
| 09/17/2024 | AngioDynamics, Inc. | ALPHAVAC (Device) | Food and Beverage | In-kind items and services | $179.25 | General |
| Category: VIT | ||||||
| 09/13/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $193.34 | General |
| Category: VTE | ||||||
| 09/12/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $34.19 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/28/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $29.06 | General |
| Category: Iron Deficiency Anemia | ||||||
| 08/22/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: Cardiology | ||||||
| 08/21/2024 | Stryker Corporation | N/A (Device) | Food and Beverage | In-kind items and services | $87.33 | General |
| Category: NAVIGATION | ||||||
| 08/20/2024 | Globus Medical, Inc. | Excelsius3D Imaging System (Device) | Food and Beverage | In-kind items and services | $81.10 | General |
| Category: Spine/Spine Surgery | ||||||
| 08/16/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $36.67 | General |
| Category: Cardiology | ||||||
| 08/07/2024 | Alphatec Spine, Inc | Battalion TLIF - PC (Device) | Food and Beverage | In-kind items and services | $237.50 | General |
| Category: Orthopedics/Orthopedic Surgery | ||||||
| 07/31/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $25.05 | General |
| Category: Iron Deficiency Anemia | ||||||
| 07/30/2024 | Alphatec Spine, Inc | Invictus MIS (Device) | Food and Beverage | In-kind items and services | $105.65 | General |
| Category: Orthopedics/Orthopedic Surgery | ||||||
| 07/30/2024 | Alphatec Spine, Inc | Invictus MIS (Device) | Food and Beverage | In-kind items and services | $77.05 | General |
| Category: Orthopedics/Orthopedic Surgery | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| An Extension Study to Assess the Safety, Tolerability, and Effectiveness of the Long-Term Use of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) | Insmed, Inc. | $1,279 | 4 |
| UNSPECIFIED RESEARCH PROJECTS | United Therapeutics Corporation | $294.29 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 385 | 664 | $364,073 | $63,615 |
| 2022 | 8 | 413 | 658 | $321,136 | $62,602 |
| 2021 | 12 | 614 | 945 | $336,876 | $85,877 |
| 2020 | 14 | 588 | 985 | $406,756 | $90,200 |
Total Patients
2,000
Total Services
3,252
Medicare Billing
$302,295
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 39 | 109 | $139,411 | $18,553 | 13.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 109 | 233 | $88,789 | $17,884 | 20.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 52 | 105 | $40,091 | $7,705 | 19.2% |
| 93451 | Insertion of tube in right heart chambers for measurement | Facility | 2023 | 73 | 77 | $43,481 | $7,493 | 17.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 62 | 62 | $30,506 | $6,752 | 22.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 16 | 25 | $7,523 | $2,519 | 33.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 34 | $9,155 | $1,814 | 19.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 17 | 19 | $5,116 | $894.88 | 17.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 110 | 234 | $87,971 | $18,628 | 21.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 37 | 80 | $65,217 | $14,468 | 22.2% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2022 | 60 | 104 | $29,732 | $8,307 | 27.9% |
| 93451 | Insertion of tube in right heart chambers for measurement | Facility | 2022 | 68 | 79 | $75,444 | $8,180 | 10.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 48 | 48 | $23,899 | $5,542 | 23.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 14 | 31 | $9,405 | $2,650 | 28.2% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2022 | 33 | 33 | $17,612 | $2,307 | 13.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 21 | 27 | $10,309 | $2,272 | 22.0% |
| 76937 | Ultrasonic guidance for blood vessel access | Facility | 2022 | 22 | 22 | $1,546 | $247.56 | 16.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 110 | 240 | $85,920 | $19,767 | 23.0% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 41 | 83 | $75,945 | $15,695 | 20.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2021 | 68 | 130 | $16,380 | $11,215 | 68.5% |
| 93451 | Insertion of catheter for diagnostic evaluation of right heart structures | Facility | 2021 | 77 | 87 | $38,541 | $9,597 | 24.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 36 | 101 | $34,643 | $8,890 | 25.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 48 | 52 | $34,684 | $8,509 | 24.5% |
| 36556 | Insertion of central venous catheter for infusion, patient 5 years or older, not tunneled | Facility | 2021 | 67 | 72 | $25,056 | $5,106 | 20.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 32 | 32 | $17,344 | $3,802 | 21.9% |
About Dr. Harrison Farber, M.D
Dr. Harrison Farber, M.D is a Internal Medicine healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1396721841.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Harrison Farber, M.D has received a total of $368,990 in payments from pharmaceutical and medical device companies, with $30,717 received in 2024. These payments were reported across 703 transactions from 33 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($142,086).
As a Medicare-enrolled provider, Farber has provided services to 2,000 Medicare beneficiaries, totaling 3,252 services with total Medicare billing of $302,295. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Pulmonary Disease
- Location Boston, MA
- Active Since 12/16/2005
- Last Updated 05/16/2014
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1396721841
Products in Payments
- Adempas (Drug) $72,174
- Letairis (Drug) $32,502
- ORENITRAM (Drug) $23,315
- OPSUMIT (Drug) $21,276
- UPTRAVI (Drug) $11,775
- OPSUMIT MACITENTAN (Drug) $10,997
- NONE (Drug) $10,565
- TYVASO (Drug) $3,064
- BOSENTAN (Drug) $1,119
- FlowTriever (Device) $760.73
- TLIF (Device) $693.01
- XLIF (Device) $678.13
- ELSA (Device) $675.10
- Invictus MIS (Device) $594.93
- Excelsius3D Imaging System (Device) $551.71
- FLOWTRIEVER CATHETER, S (Device) $430.56
- REMODULIN (Drug) $395.71
- OFEV (Drug) $366.80
- LifeVest (Device) $356.47
- Pulse (Device) $269.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Boston
Michael Mendelsohn, M.d, M.D
Internal Medicine — Payments: $4.6M
Internal Medicine $4.6M
David Schenkein, Md, MD
Internal Medicine — Payments: $4.0M
Internal Medicine $4.0M
Dr. John Fallon, M.d, M.D
Internal Medicine — Payments: $2.5M
Internal Medicine $2.5M
Dr. David Scadden, Md, MD
Internal Medicine — Payments: $2.2M
Internal Medicine $2.2M
Dr. James Januzzi, Md, MD
Internal Medicine — Payments: $1.8M
Internal Medicine $1.8M
Dr. Marilyn Pike, Md Phd, MD PHD
Internal Medicine — Payments: $1.5M
Internal Medicine $1.5M